Toronto, Canada
Future Fertility, founded in 2018, is a pioneering Canada-based med-tech startup leveraging Artificial Intelligence to advance reproductive medicine. The company operates in the AI, Biotechnology, Health Care, and Machine Learning sectors, utilizing cutting-edge image analysis software tools, VIOLET™ and MAGENTA™, to assess the reproductive potential of human oocytes.
Their flagship tool, Violet, delivers a non-invasive predictive analysis with a remarkable 90% accuracy in determining successful fertilization prospects, and a 65% rate for blastocyst formation. Such capabilities offer critical, objective insights, enabling personalized patient feedback and optimized IVF treatment strategies. This innovation not only enhances patient outcomes but also positions the company as a frontrunner in the field of reproductive AI.
Future Fertility secured a Series A investment on 06 January 2022, backed by MERL Ventures Fund and Whitecap Venture Partners. The investment signifies confidence in the company's potential to revolutionize reproductive medicine through AI-driven solutions.
Spring Fertility